土耳其五岁以下健康儿童肺炎链球菌鼻咽携带率与血清型分布
该横断面研究于2019年3月至2020年3月在土耳其五个中心纳入580名接种PCV13的五岁以下健康儿童,采集鼻咽拭子。总体肺炎链球菌携带率为17.8%,最常见血清型为15B、23F、23A等,仅27.2%分离株属于PCV13疫苗血清型,72.8%为非疫苗血清型,提示血清型替换。
要点
- PCV13接种儿童肺炎链球菌总携带率为17.8%。
- 仅27.2%分离株为PCV13疫苗血清型,72.8%为非疫苗血清型。
- 母亲高教育水平与携带风险降低相关(OR 1.992,95%CI 1.089-3.643,p=0.025)。
核心结论
- PCV13接种的健康五岁以下儿童肺炎链球菌总携带率高于土耳其早期研究。
- 研究观察到疫苗血清型减少和非疫苗血清型替换现象,与全球疫苗接种后趋势一致。
研究设计与样本
- 横断面研究,2019年3月至2020年3月在土耳其五个中心纳入580名五岁以下健康儿童。
- 采集问卷数据和鼻咽拭子,用奥普托欣敏感性和胆汁溶解试验鉴定肺炎链球菌,用乳胶凝集试剂盒和Quellung反应进行血清分型。
主要发现
- 580名健康儿童鼻咽拭子总携带率为17.8%。
- 除母亲教育水平外,其他假设预测因素与肺炎链球菌携带无统计学显著关联(p=0.017)。
- 母亲高教育水平降低携带风险(较低 vs. 较高母亲教育水平 OR:1.992 [95%CI 1.089-3.643],p=0.025)。
- 最常见血清型为15B(n=10,9.7%)、23F(n=9,8.7%)、23A(n=9,8.7%)、11A(n=7,6.7%)、19F(n=5,4.8%)和15F(n=5,4.8%)。
- 28株(27.2%)为PCV13疫苗血清型,75株(72.8%)为非疫苗血清型;PCV13血清型覆盖率为27.2%。
关键数值与推荐
- 总携带率17.8%(103/580)。
- PCV13疫苗血清型占比27.2%(28株),非疫苗血清型占比72.8%(75株)。
- 母亲教育水平与携带风险相关:较低 vs. 较高教育水平 OR 1.992(95%CI 1.089-3.643),p=0.025。
临床怎么用
- 在PCV13接种儿童中需关注非疫苗血清型携带增加,评估血清型替换对防控策略的影响。
- 母亲教育水平可作为肺炎链球菌携带风险的参考因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In Turkey, pneumococcal conjugate vaccine (PCV) was introduced to the national immunization program as PCV7 in 2008, and was replaced with PCV13 in 2011. The aim of the study was to demonstrate the pneumococcal carriage rate and the serotype distribution in healthy children under 5 years in Turkey who were vaccinated with PCV13. METHODS: We conducted a cross-sectional study including the collection of questionnaire data and nasopharyngeal (NP) specimens among children aged <5 years from five centers from March 2019 to March 2020. Pneumococcal isolates were identified using optochin sensitivity and bile solubility. Serotyping was performed using a latex agglutination kit and Quellung reaction. RESULTS: NP swab samples were collected from 580 healthy children. The observed overall carriage rate was 17.8%. None of the hypothesised predictors of S. pneumoniae carriage, except maternal education level was statistically significant (p = 0.017). High maternal education level appeared to decrease the risk (lower vs. higher maternal education OR: 1.992 [95% CI; 1.089-3.643], p = 0.025). The overall NP S. pneumoniae carriage prevalence for the PCV13-vaccinated children was 17.8% (103/580). The most common serotypes detected were serotype 15B (n = 10, 9.7%), serotype 23F (n = 9, 8.7%), serotype 23A (n = 9, 8.7%), serotype 11A (n = 7, 6.7%), serotype 19F (n = 5, 4.8%) and serotype 15F (n = 5, 4.8%). Of the isolates, 28 (27.2%) were in PCV13 vaccine strains (VSs), and 75 (72.8%) strains were non-VS. The serotype coverage rate was 27.2% for PCV13. CONCLUSION: The overall S. pneumoniae carriage rate was higher than in earlier studies from Turkey. Post-vaccine era studies from around the world have reported a decrease in VS serotypes and a 'serotype replacement' to non-VS serotypes, as we determined in our study.
引用
- Ceyhan M, Karadag-Oncel E, Hascelik G, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children aged less than five years. Vaccine. 2021. PMID: 33741188. doi:10.1016/j.vaccine.2021.03.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。